BNP Paribas Financial Markets’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2
Closed -$466 5677
2025
Q2
$466 Hold
2
﹤0.01% 5230
2025
Q1
$562 Hold
2
﹤0.01% 5131
2024
Q4
$680 Buy
+2
New +$630 ﹤0.01% 5131
2022
Q4
Sell
-2
Closed -$1.32K 4336
2022
Q3
$1.32K Sell
2
-28
-93% -$22K ﹤0.01% 4397
2022
Q2
$22.6K Buy
30
+28
+1,400% +$43.9K ﹤0.01% 3685
2022
Q1
$7.32K Sell
2
-177
-99% -$464K ﹤0.01% 3832
2021
Q4
$540K Buy
179
+175
+4,375% +$812K ﹤0.01% 2977
2021
Q3
$28K Buy
4
+3
+300% +$25.9K ﹤0.01% 3611
2021
Q2
$12.1K Sell
1
-1
-50% -$15.7K ﹤0.01% 3676
2021
Q1
$34.8K Sell
2
-2
-50% -$39K ﹤0.01% 3684
2020
Q4
$65.1K Hold
4
﹤0.01% 3430
2020
Q3
$76.2K Buy
4
+3
+300% +$69K ﹤0.01% 3259
2020
Q2
$17.8K Sell
1
-2
-67% -$56.7K ﹤0.01% 3448
2020
Q1
$73.1K Buy
3
+1
+50% +$16K ﹤0.01% 3366
2019
Q4
$15.2K Buy
2
+1
+100% +$9.66K ﹤0.01% 4063
2019
Q3
$11.1K Hold
1
﹤0.01% 4135
2019
Q2
$11.9K Hold
1
﹤0.01% 4064
2019
Q1
$28.2K Buy
+1
New +$17.8K ﹤0.01% 3797
2018
Q4
Hold
0
3827
2018
Q3
Hold
0
4041
2018
Q2
Sell
-1
Closed -$38.4K 3936
2018
Q1
$45.9K Hold
1
﹤0.01% 3610
2017
Q4
$28.7K Buy
+1
New +$46.8K ﹤0.01% 3893
2017
Q3
Hold
0
3979

Other funds holding KALA

BNP Paribas Financial Markets's KALA Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of KALA BIO (KALA) in Q3 2025, closing a stake of 2 shares — an estimated $466 sold.

BNP Paribas Financial Markets first reported a position in KALA in Q4 2017 and held it in 20 quarters. The position peaked at $540K in Q4 2021. 22 funds tracked by Wall St. Rank hold KALA as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining KALA BIO position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2 KALA BIO shares in Q3 2025, an estimated $466.
  • BNP Paribas Financial Markets first reported a position in KALA BIO in Q4 2017 and held it in 20 quarters.
  • BNP Paribas Financial Markets's KALA BIO position peaked at $540K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held KALA BIO as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.